Pathstone Family Office’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,912
| Closed | -$219K | – | 1685 |
|
|
2023
Q2 | $219K | Sell |
3,912
-461
| -11% | -$25.8K | ﹤0.01% | 1105 |
|
|
2023
Q1 | $244K | Sell |
4,373
-5,039
| -54% | -$281K | ﹤0.01% | 1004 |
|
|
2022
Q4 | $526K | Buy |
+9,412
| New | +$526K | ﹤0.01% | 1071 |
|
|
2022
Q1 | – | Sell |
-1,931
| Closed | -$288K | – | 1014 |
|
|
2021
Q4 | $288K | Buy |
1,931
+113
| +6% | +$16.9K | 0.01% | 725 |
|
|
2021
Q3 | $264K | Buy |
1,818
+663
| +57% | +$96.3K | 0.01% | 718 |
|
|
2021
Q2 | $226K | Buy |
+1,155
| New | +$226K | 0.01% | 734 |
|
|
2021
Q1 | – | Sell |
-70
| Closed | -$10K | – | 1277 |
|
|
2020
Q4 | $10K | Sell |
70
-70
| -50% | -$10K | ﹤0.01% | 871 |
|
|
2020
Q3 | $17K | Buy |
+140
| New | +$17K | ﹤0.01% | 512 |
|